CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|12|1227-1246

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.12, 2015-07, pp. : 1227-1246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo

By  

THE PROSTATE, Vol. 75, Iss. 8, 2015-06 ,pp. : 815-824

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of IL‐6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1035-1046

John Wiley & Sons Inc

Access to resources Recommend Favorite

Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1300-1311

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors Affecting Progression and Survival in Metastatic Prostate Cancer

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer

By  

Case Reports in Oncology, Vol. 3, Iss. 1, 2010-03 ,pp. : 63-71

Karger

Access to resources Recommend Favorite